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BellaGen
TM is an injectable acellular dermal matrix granule 
derived from donated human skin tissue that was recently 
developed for soft tissue augmentation. Its use has been 
sporadically reported in penile girth enhancement pro-
cedures. Many cases of complications have been reported 
after injecting acellular dermal matrices like AlloDerm or 
SureDerm
TM but few reports on complications associated 
with BellaGen
TM injection. We report here on penile skin 
inflammation and necrosis following augmentation phallo-
plasty with BellaGen
TM, which developed 3 days after the 
injection and persisted for more than 2 weeks. The patient 
had a 15 year history of type 2 diabetes mellitus, and he was 
treated with oral antibiotics and wet dressings with KMNO4 
solution to combine preservation of the remaining penile soft 
tissue with debridement of avascular tissue. The lesion 
improved with this treatment, but the patient experienced 
pain for about 2 weeks. All patients should be informed of the 
potential complications with the use of injectable acellular 
dermal matrices before treatment. Patient selection for 
augmentation is also important to have the most desirable 
results. (Ann Dermatol 23(S3) S306∼S309, 2011)
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INTRODUCTION
Aesthetic augmentation of the penis has generated in-
creasing interest among men. Most men who request 
surgical penile enhancement have a normal-sized and 
fully functional penis but perceive their penises to be 
small. This feeling can be exacerbated by advertising in 
the media
1. There are no recommended indications for 
penile girth enhancement procedures in the medical 
literature, and no guidelines have been proposed for this 
technique
2. The injection of exogenous substances, such 
as autologous fat, silicone, hyaluronic acid gel, and 
dermal fat into the genital skin to cause penile enlarge-
ment occurs in many cultures
3. BellaGen
TM (Hans Biomed, 
Seoul, Korea) is an injectable, inert, acellular dermal 
matrix that is intended for the repair or replacement of 
damaged soft tissue. Recently, SureDerm
TM (Hans Biomed, 
Seoul, Korea), a pro-powdered state acellular dermal 
matrix, has been used as an alternative to autologous fat 
injections or dermal fat grafts for penile girth enhance-
ment
4. As BellaGen
TM injections are more convenient and 
faster than SureDerm
TM, many local clinics use this 
product for soft tissue augmentation. Complications from 
BellaGen
TM-based phalloplasties have not been described 
in the literature. We report here on an inflammatory 
reaction and necrosis secondary to the injection of 
BellaGen
TM for the enhancement of penile girth. 
CASE REPORT
A 50-year-old Korean male presented to our department 
with a painful ulcer on the dorsal side of the penis. He 
had received injections of BellaGen
TM in the penis for 
penile girth enhancement at a private urology clinic 2 
weeks prior. Three days after the injections, erythema and 
intermittent swelling were noted on the dorsal side of the 
penis, and an erosive, severely painful lesion subsequently 
developed. Conservative wound management had been Complications Following BellaGen
TM Injection
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Fig. 1. When the patient initially visited our department, he 
presented with a necrotic change with erosive lesions of the 
glans penis and the dorsal side of penis.
Fig. 2. Histopathological examination showed a moderate lymphohistiocytic infiltration with necrotic change (H&E, A: ×40, B: ×100).
Fig. 3. 8 weeks after he visited our department, the lesion 
improved.
prescribed, but the patient reported little improvement. 
On exam, there was an erosive lesion with necrotic 
changes of the glans penis and the dorsal side of the penis 
(Fig. 1). Otherwise, the remainder of the physical examination 
was unremarkable. The patient had a 15 year history of 
type II diabetes mellitus with poor glucose control. Penile 
and scrotal magnetic resonance imaging was normal. A 
biopsy was performed with a working diagnosis of foreign 
body reaction.
The histopathological examination showed a moderate 
lymphohistiocytic infiltration with necrotic changes (Fig. 2).
The patient was treated with conservative wound manage-
ment--wet dressings with KMNO4 solution, occlusion 
with gauze of petroleum jelly, and a 4-week course of oral 
antibiotics. During treatment, he developed complete skin 
necrosis of the glans penis. He underwent aggressive 
debridement of the necrotic penile skin, and conservative 
wound care was continued. After 8 weeks, the lesion 
improved, and his pain gradually decreased (Fig. 3). 
DISCUSSION
Acellular inert dermal matrices derived from donated 
human skin tissue have been sporadically used for soft 
tissue augmentation in many medical departments
5-7. 
Recently, with increasing numbers of patients paying 
attention to aesthetics and cosmetics, acellular dermal 
matrices have even been used for penile girth procedures. 
The use of AlloDerm for penile girth enhancement has the MK Park, et al
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potential to provide a more consistent cosmetic result with 
respect to symmetry and durability. It is also associated 
with a lower relative incidence of adverse effects when 
compared to dermal fat grafting
3.
Zhang et al.
8 reported that penile enlargement by implan-
tation of multiple layers of acellular dermal matrix was a 
safe and effective operation. SureDerm
TM is a sheet-type of 
AlloDerm made in Korea. These sheets have been placed 
above the superficial lamina of Buck’s fascia at the 
interface with the dartos fascia to enhance penile and 
granular girth
3. The advantages of this technique are 
many: no rejection response, no donor-site scarring, good 
graft survival, and a low complication rate
4. Despite its 
many advantages, it still requires a fairly complex pro-
cedure and insertion time. To make the product less time 
consuming, it was made into a powdered form and com-
mercialized as BellaGen
TM. BellaGen
TM is an injectable 
form of an acellular dermal matrix that is easy to insert 
and requires less injection time, garnering a favorable 
reception by office workers since its introduction. 
Despite the many advantages of acellular dermal matrices, 
when used to enhance penile girth in a cosmetic phallo-
plasty, the viability of the overlying thin and delicate 
penile skin can be compromised. Other complications 
associated with the use of acellular dermal matrices 
include erosion, fibrosis, infection, resorption, and skin 
loss, which can have a detrimental effect on penile length 
and function
9. Due to limited data, the use of acellular 
dermal matrices in penile girth enhancements must be 
closely scrutinized. 
In our presented case, necrosis of the glans and dorsal 
penile skin occurred after BellaGen
TM injection, creating a 
unique and difficult problem to manage. There are several 
explanations for why this complication may have occurred. 
The cause of the skin necrosis was likely from disruption 
of the underlying penile vasculature. The arterial blood 
supply to the penile shaft and prepuce is provided by the 
bilateral superficial penile arteries, which branch from the 
inferior external pudendal arteries
9. Our patient had a 
15-year history of diabetes with poor glucose control. 
High blood sugar levels can damage nerves and contri-
bute to blood vessel narrowing, thereby disrupting the 
nerve and blood supply to the penis. In addition to poorly 
controlled diabetes, the BellaGen
TM, though theoretically 
providing increased cosmetic girth, was an avascular 
component introduced into the tissues and may have 
inhibited the onset of inosculation, ultimately hindering 
skin viability
10. The location of the injection is also impor-
tant to note. Unlike acellular dermal matrix sheets, injec-
tions can more easily be misplaced due to variations in 
needle depth or an operator’s mistake. Dermal matrix 
should be placed above the superficial lamina of Buck’s 
fascia at the interface with the dartos fascia
3, but if the 
dermal matrix were to reach the carvernosum of the penis, 
it could cause necrosis. Though rare, dermal matrix could 
also cause an allergic reaction. Acellular dermal matrix, 
like hyaluronic acid, has no organ or species specificity 
and theoretically poses no risk of allergy. However, 
Micheels
11 has reported the presence of circulating anti-
bodies against hyaluronic acid in patients, which supports 
the allergy hypothesis given that it is possible for cir-
culating antibodies against dermal matrix to exist. Our 
patient experienced inflammatory reactions after the 
intradermal injections, complaining of severe redness, 
swelling, pain, and tenderness, which may have been 
allergic reactions. 
We treated our patient with conservative wound manage-
ment, oral antibiotics, and aggressive debridement of 
necrotic skin, which improved the condition of the lesion. 
However, he looked behind distressing days after pro-
cedures. 
This case demonstrated an inflammatory and necrotic 
reaction to locally injected BellaGen
TM. Though rare, 
acellular dermal matrix injections for cosmetic purposes 
may produce severe side effects. With the increasing 
availability of diverse soft tissue augmentation materials, 
physicians should be aware of this complication from 
injectable acellular dermal matrix and carefully consider 
whether patients interested in receiving injections may 
have any diseases that would influence blood supply and 
tissue viability. 
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